1-2 of 2
Jill Burke
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Final Results of a Phase 2 Study of Modified Lenalidomide, Bortezomib, and Dexamethasone (RVD lite) in Transplant-Ineligible Multiple Myeloma

Elizabeth O'Donnell, MD, Jacob Laubach, MD, Andrew J Yee, MD, Tianqi Chen, Carol Ann Huff, MD, Frank G. Basile, MD, Philip Wade, MD, Claudia Paba-Prada, MD, Irene M. Ghobrial, MD, Robert Schlossman, MD, Jill Burke, Harrington Cynthia, Kathleen Lively, Hannah Lyons, Nikhil Munshi, MD, Lorenzo Trippa, PhD, Kenneth C Anderson, MD, Paul G Richardson, MD, Noopur Raje, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3126.
https://doi.org/10.1182/blood.V130.Suppl_1.3126.3126
Published: 2017
Journal Articles

Updated Results of a Phase I Study of RAD001 In Combination with Lenalidomide In Patients with Relapsed or Refractory Multiple Myeloma with Pharmacodynamic and Pharmacokinetic Analysis

Anuj Mahindra, MD, Paul G Richardson, Parameswaran Hari, MD, Aliyah R. Sohani, MD, Jacob P. Laubach, MD, Jill Burke, NP, Sarah Kaster, Christine Connolly, Linda Rivera, Paulette Jacobs, Ayman Saad, MD, Kathleen Colson, RN, Irene Ghobrial, MD, Robert L. Schlossman, MD, Jennifer Adams, Wendy Makrides, Edie Weller, Nikhil C. Munshi, MD, Kenneth C. Anderson, Noopur Raje, MD
Journal: Blood
Blood (2010) 116 (21): 3051.
https://doi.org/10.1182/blood.V116.21.3051.3051
Published: 2010